GREM1 and glioblastoma: siRNA-mediated knockdown of GREM1 in U87-MG glioblastoma cells induced cell cycle arrest and apoptosis, and abolished TGF-β1-mediated activation of SMAD2 signaling, inhibiting EMT in these cells [55].